{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:57:00Z","timestamp":1780574220906,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1053\/j.ajkd.2020.07.023","type":"journal-article","created":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T23:28:40Z","timestamp":1605396520000},"page":"704-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["\u03b2-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis"],"prefix":"10.1053","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6491-7745","authenticated-orcid":false,"given":"Hui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally F.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Sum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Neyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ajkd.2020.07.023_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00041552-200403000-00004","article-title":"The association between congestive heart failure and chronic renal disease","volume":"13","author":"Silverberg","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"10.1053\/j.ajkd.2020.07.023_bib2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s11255-018-1837-6","article-title":"Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters","volume":"50","author":"Sim","year":"2018","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.023_bib3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ki.1995.132","article-title":"Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors","volume":"47","author":"Harnett","year":"1995","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.023_bib4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2215\/CJN.07130810","article-title":"Heart failure in long-term peritoneal dialysis patients: a 4-year prospective analysis","volume":"6","author":"Wang","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3 suppl 1","key":"10.1053\/j.ajkd.2020.07.023_bib5","first-page":"S1","article-title":"US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States","volume":"71","author":"Saran","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ajkd.2020.07.023_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.023_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hfc.2012.09.003","article-title":"Comparative effectiveness research in heart failure therapies: women, elderly patients, and\u00a0patients with kidney disease","volume":"9","author":"Shah","year":"2013","journal-title":"Heart Fail Clin"},{"issue":"6","key":"10.1053\/j.ajkd.2020.07.023_bib8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.07.023_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9343(01)00652-0","article-title":"Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction","volume":"110","author":"Shlipak","year":"2001","journal-title":"Am J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.023_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gft515","article-title":"Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2020.07.023_bib11","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.07.023_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000321102","article-title":"Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure","volume":"30","author":"Cnossen","year":"2010","journal-title":"Blood Purif"},{"issue":"2","key":"10.1053\/j.ajkd.2020.07.023_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0002-8703(68)90198-1","article-title":"Clinical and hemodynamic results of peritoneal dialysis for severe cardiac failure","volume":"76","author":"Cairns","year":"1968","journal-title":"Am Heart J"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.023_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3747\/pdi.2012.00149","article-title":"Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics","volume":"34","author":"Courivaud","year":"2014","journal-title":"Perit Dial Int"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2020.07.023_bib15","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1177\/089686089601601S43","article-title":"PD treatment for severe congestive heart failure","volume":"16","author":"Stegmayr","year":"1996","journal-title":"Perit Dial Int"},{"issue":"6","key":"10.1053\/j.ajkd.2020.07.023_bib16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.sapharm.2014.12.007","article-title":"Association between higher rates of cardioprotective drug use and survival in patients on dialysis","volume":"11","author":"Tang","year":"2015","journal-title":"Res Social Adm Pharm"},{"key":"10.1053\/j.ajkd.2020.07.023_bib17","doi-asserted-by":"crossref","first-page":"937398","DOI":"10.1155\/2014\/937398","article-title":"Heart failure in patients with chronic kidney disease: a systematic integrative review","volume":"2014","author":"Segall","year":"2014","journal-title":"Biomed Res Int"},{"issue":"11","key":"10.1053\/j.ajkd.2020.07.023_bib18","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jacc.2011.04.041","article-title":"Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"58","author":"Badve","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.023_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/hdi.12783","article-title":"Beta-blocker practice patterns in chronic kidney disease patients with atrial fibrillation transitioning to hemodialysis","volume":"23","author":"Lee","year":"2019","journal-title":"Hemodial Int"},{"issue":"5 suppl","key":"10.1053\/j.ajkd.2020.07.023_bib20","first-page":"S9","article-title":"Contemporary use of \u03b2-blockers: clinical relevance of subclassification","volume":"30","author":"Poirier","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.ajkd.2020.07.023_bib21","first-page":"607","article-title":"Pharmacokinetics of antihypertensive drugs (atenolol, metoprolol, propranolol and clonidine) and their metabolites during intermittent haemodialysis in humans","volume":"15","author":"Niedermayer","year":"1978","journal-title":"Proc Eur Dial Transplant Assoc"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.023_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2215\/CJN.07470717","article-title":"\u03b2-Blocker dialyzability in maintenance hemodialysis patients: a randomized clinical trial","volume":"13","author":"Tieu","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.023_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1681\/ASN.2014040324","article-title":"\u03b2-Blocker dialyzability and mortality in older patients receiving hemodialysis","volume":"26","author":"Weir","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.023_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.ajkd.2018.02.350","article-title":"A\u00a0comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis","volume":"72","author":"Assimon","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.023_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.amepre.2018.05.026","article-title":"Low systolic blood pressure from treatment and association with serious falls\/syncope","volume":"55","author":"Sim","year":"2018","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1053\/j.ajkd.2020.07.023_bib26","first-page":"544","article-title":"Systemic implementation strategies to improve hypertension: the Kaiser Permanente Southern California experience","volume":"30","author":"Sim","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.ajkd.2020.07.023_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of\u00a0a large, integrated health care system: comparison with\u00a0US\u00a0Census Bureau data","author":"Koebnick","year":"2012","journal-title":"The Permanente Journal"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.023_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1460458216651917","article-title":"Extracting and analyzing ejection fraction values from electronic echocardiography reports in a large health maintenance organization","volume":"23","author":"Xie","year":"2017","journal-title":"Health Informatics J"},{"issue":"28","key":"10.1053\/j.ajkd.2020.07.023_bib29","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"2","key":"10.1053\/j.ajkd.2020.07.023_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1524-4733.2009.00671.x","article-title":"Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals","volume":"13","author":"Xu","year":"2010","journal-title":"Value Health"},{"key":"10.1053\/j.ajkd.2020.07.023_bib31","author":"Jacob","year":"1988"},{"issue":"6","key":"10.1053\/j.ajkd.2020.07.023_bib32","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"3 suppl 1","key":"10.1053\/j.ajkd.2020.07.023_bib33","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2020.07.023_bib34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.ajkd.2018.12.011","article-title":"Mortality in incident maintenance dialysis patients versus incident solid organ cancer patients: a population-based cohort","volume":"73","author":"Naylor","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.023_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000496083","article-title":"Effects of beta-blockers on cardiovascular events and mortality in dialysis patients: a systematic review and meta-analysis","volume":"48","author":"Jin","year":"2019","journal-title":"Blood Purif"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.023_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijcard.2011.09.037","article-title":"\u03b2-Blocker prevents sudden cardiac death in\u00a0patients with hemodialysis","volume":"165","author":"Matsue","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.07.023_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0735-1097(00)01158-X","article-title":"Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial","volume":"37","author":"Cice","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.023_bib38","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/ndt\/gfr460","article-title":"Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada","volume":"27","author":"Kitchlu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.023_bib39","doi-asserted-by":"crossref","first-page":"e002584","DOI":"10.1161\/JAHA.115.002584","article-title":"Prognostic benefits of carvedilol, bisoprolol, and metoprolol controlled release\/extended release in hemodialysis patients with heart failure: a 10-year cohort","volume":"5","author":"Tang","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"14","key":"10.1053\/j.ajkd.2020.07.023_bib40","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.023_bib41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1053\/j.ajkd.2020.07.023_bib42","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1053\/j.ajkd.2020.07.023_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10840-010-9484-6","article-title":"Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients","volume":"28","author":"Khan","year":"2010","journal-title":"J\u00a0Interv Card Electrophysiol"},{"issue":"13","key":"10.1053\/j.ajkd.2020.07.023_bib44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200003303421301","article-title":"Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study","volume":"342","author":"Gress","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2020.07.023_bib45","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.amjcard.2007.05.057","article-title":"A\u00a0meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus","volume":"100","author":"Bangalore","year":"2007","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.023_bib46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000046255","article-title":"Life-threatening hyperkalemia after intravenous labetolol injection for hypertensive emergency in a hemodialysis patient","volume":"21","author":"Hamad","year":"2001","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.023_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1525-139X.2011.01016.x","article-title":"The intuitive case for \u03b2-blockers in patients with ESRD","volume":"25","author":"McQuillan","year":"2012","journal-title":"Semin Dial"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.023_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/sdi.12691","article-title":"Beta blockers in patients with end-stage renal disease-Evidence-based recommendations","volume":"31","author":"Weir","year":"2018","journal-title":"Semin Dial"},{"issue":"5","key":"10.1053\/j.ajkd.2020.07.023_bib49","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.ajkd.2016.12.006","article-title":"Sudden cardiac death among hemodialysis patients","volume":"69","author":"Makar","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2020.07.023_bib50","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.hrthm.2009.08.006","article-title":"Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation","volume":"6","author":"Aggarwal","year":"2009","journal-title":"Heart Rhythm"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620310015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620310015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:34:45Z","timestamp":1759462485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638620310015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0272638620310015"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.07.023","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}